Actos Linked with Slowed Rate of Atherosclerosis Progression
June 8th, 2009 by Nina Thompson, ARNP
Actos (pioglitazone), an oral drug used in Diabetes, appears to slow the rate of atherosclerosis in the carotid arteries, according to researchers at the Phoenix VA HealthCare System.
In their recent study, prediabetic patients taking pioglitazone preventively had a 38% lower rate of change in atherosclerotic progression in the carotid artery over three years compared to patients taking placebo.
Cholesterol is [...]
Bookmark this page
E-mail this story
Print this post
